Bristol-Myers Squibb Company (FRA:BRM)
48.24
-0.13 (-0.28%)
At close: Jan 9, 2026
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€1,200,568
Profits / Employee
€150,940
Market Cap
97.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Bristol-Myers Squibb Company News
- 4 days ago - Bristol-Myers Squibb (BMY) Upgraded to Buy with Raised Price Target | BMY Stock News - GuruFocus
- 9 days ago - Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? - Benzinga
- 9 days ago - Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference - Wallstreet:Online
- 11 days ago - Looking Into Bristol-Myers Squibb Co's Recent Short Interest - Benzinga
- 11 days ago - Ex-Dividend Reminder: Encompass Health, Bristol Myers Squibb and Federal Realty Investment Trust - Nasdaq
- 11 days ago - Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026? - Nasdaq
- 12 days ago - Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026? - The Motley Fool
- 12 days ago - Biotech Stocks Facing FDA Decision In January 2026 - Nasdaq